1.28

5.79% 0.07

After Hours: 1.21 -0.07 -5.47%

Bionano Genomics Inc (BNGO)

Overview News Price History Option Chain Financials Why BNGO Down? Discussions Forecast Stock Split

Bionano Genomics Inc stock is traded at $1.28, with a volume of 146.82K. It is up +5.79% in the last 24 hours and up +15.32% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Previous Close:

$1.21

Open:

$1.2

24h Volume:

146.82K

Relative Volume:

0.46

Market Cap:

$14.20M

Revenue:

$28.51M

Net Income/Loss:

$-26.40M

P/E Ratio:

-0.2338

EPS:

-5.4756

Net Cash Flow:

$-16.35M

1W Performance:

+8.47%

1M Performance:

+15.32%

6M Performance:

-39.48%

1Y Performance:

-71.36%

1-Day Range:

$1.20

$1.28

1-Week Range:

$1.1201

$1.28

52-Week Range:

$1.06

$5.50

Bionano Genomics Inc Stock (BNGO) Company Profile

Name

Bionano Genomics Inc

Sector

Healthcare (1112)

Industry

Medical Instruments & Supplies (57)

Phone

(858) 888-7600

Address

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

Employee

Twitter

@bionanogenomics

Next Earnings Date

2026-03-23

Latest SEC Filings

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNGO Bionano Genomics Inc	1.28	13.42M	28.51M	-26.40M	-16.35M	-5.4756
ISRG Intuitive Surgical Inc	468.36	165.94B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.52	44.30B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	80.73	38.96B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.93	38.69B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	228.80	33.61B	5.40B	1.49B	1.78B	10.12

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-12-22	Resumed	BTIG Research	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Jun-16-21	Initiated	BTIG Research	Buy
Sep-24-20	Initiated	Ladenburg Thalmann	Buy
Apr-08-20	Initiated	Oppenheimer	Outperform

View All

Bionano Genomics Inc Stock (BNGO) Latest News

Apr 14, 2026

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN

Apr 14, 2026

Apr 13, 2026

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Apr 13, 2026

BNGO Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

Apr 13, 2026

Take Profit: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Investment Report & Community Driven Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Keys to Succeed in the Booming $300 Million Optical Genome - GlobeNewswire

Apr 13, 2026

Breakout Zone: What is Bionano Genomics Incs P E ratio telling us2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn

Apr 13, 2026

Aug Update: Is Bionano Genomics Inc part of any ETFQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn

Apr 13, 2026

Bionano Genomics stock price target lowered to $6 by H.C. Wainwright - Investing.com

Apr 13, 2026

Apr 06, 2026

Weekly Recap: Is Bionano Genomics Inc stock a value trap2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail

Apr 04, 2026

Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN

Apr 04, 2026

Apr 03, 2026